Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Phio Pharmaceuticals Corp. (PHIO) had Return on Tangible Equity of -32.84% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-4.14M |
|
-- |
|
-- |
|
$4.27M |
|
$-4.27M |
|
$0.13M |
|
$-4.14M |
|
$-4.14M |
|
$-4.14M |
|
$-4.14M |
|
$-4.14M |
|
$-4.14M |
|
$-4.27M |
|
$-4.27M |
|
11.62M |
|
11.62M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$14.30M |
|
$0.01M |
|
$0.01M |
|
$14.31M |
|
$1.71M |
|
-- |
|
-- |
|
$1.71M |
|
$12.60M |
|
$12.60M |
|
$12.60M |
|
11.62M |
|
| Cash Flow Statement Financials | |
$-8.04M |
|
$0.00M |
|
-- |
|
$21.03M |
|
$13.00M |
|
$-8.04M |
|
$0.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-32.84% |
|
|
Return on Tangible Equity |
-32.84% |
-28.92% |
|
-32.84% |
|
$1.08 |
|
$-0.69 |
|
$-0.69 |
|